Apures Co (XKRX:149300) FCF Margin % : -747.62% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Apures Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Apures Co's Free Cash Flow for the six months ended in Dec. 2023 was ₩-4,926.2 Mil. Apures Co's Revenue for the six months ended in Dec. 2023 was ₩658.9 Mil. Therefore, Apures Co's FCF Margin % for the quarter that ended in Dec. 2023 was -747.62%.

As of today, Apures Co's current FCF Yield % is -29.50%.

The historical rank and industry rank for Apures Co's FCF Margin % or its related term are showing as below:

XKRX:149300' s FCF Margin % Range Over the Past 10 Years
Min: -1536.67 Med: -824.23 Max: -358.12
Current: -747.62

During the past 10 years, the highest FCF Margin % of Apures Co was -358.12%. The lowest was -1536.67%. And the median was -824.23%.

XKRX:149300's FCF Margin % is ranked worse than
91.52% of 224 companies
in the Medical Diagnostics & Research industry
Industry Median: -11.09 vs XKRX:149300: -747.62

Apures Co FCF Margin % Historical Data

The historical data trend for Apures Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apures Co FCF Margin % Chart

Apures Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-358.12

-1,415.94

-550.03

-407.68

-747.62

Apures Co Semi-Annual Data
	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
FCF Margin %	Get a 7-Day Free Trial					-358.12	-1,415.94	-550.03	-407.68	-747.62

Competitive Comparison of Apures Co's FCF Margin %

For the Diagnostics & Research subindustry, Apures Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apures Co's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Apures Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Apures Co's FCF Margin % falls into.

Apures Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Apures Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-4926.199	/	658.916
	=	-747.62 %

Apures Co's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-4926.199	/	658.916
	=	-747.62 %

Apures Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Apures Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Apures Co (XKRX:149300) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Apures Co Ltd (XKRX:149300) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

44, Hansan-gil, Cheongbuk-eup, Gyeonggi-do, Pyeongtaek-si, KOR, 17792

Website

http://www.apures.com

Apures Co Ltd is a South Korea based company engaged in the development of transgenic animals to support bio heterogeneous long-term commercialization and new drug efficacy research. It has focused its research capabilities on developing transgenic mini pigs based on gene editing technology and somatic cell nuclear transfer technology.

Apures Co (XKRX:149300) Headlines

No Headlines